A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 166,546 shares of MNKD stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166,546
Previous 168,105 0.93%
Holding current value
$1.17 Million
Previous $877,000 19.16%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$5.01 - $6.7 $7,810 - $10,445
-1,559 Reduced 0.93%
166,546 $1.05 Million
Q2 2024

Jul 19, 2024

BUY
$4.05 - $5.43 $49,482 - $66,343
12,218 Added 7.84%
168,105 $877,000
Q1 2024

Apr 22, 2024

BUY
$3.25 - $5.27 $56,338 - $91,355
17,335 Added 12.51%
155,887 $706,000
Q4 2023

Jan 16, 2024

SELL
$3.34 - $4.29 $51,372 - $65,984
-15,381 Reduced 9.99%
138,552 $504,000
Q3 2023

Oct 24, 2023

SELL
$3.91 - $5.45 $4,105 - $5,722
-1,050 Reduced 0.68%
153,933 $635,000
Q2 2023

Jul 25, 2023

BUY
$3.72 - $4.79 $21,985 - $28,308
5,910 Added 3.96%
154,983 $630,000
Q1 2023

Apr 14, 2023

BUY
$3.95 - $5.63 $11,316 - $16,129
2,865 Added 1.96%
149,073 $611,000
Q4 2022

Feb 08, 2023

BUY
$3.02 - $5.37 $15,673 - $27,870
5,190 Added 3.68%
146,208 $770,000
Q3 2022

Oct 25, 2022

BUY
$2.99 - $4.35 $8,536 - $12,419
2,855 Added 2.07%
141,018 $436,000
Q2 2022

Aug 12, 2022

BUY
$2.67 - $4.77 $67,404 - $120,418
25,245 Added 22.36%
138,163 $526,000
Q1 2022

May 11, 2022

BUY
$2.62 - $4.45 $240,128 - $407,851
91,652 Added 430.98%
112,918 $416,000
Q4 2021

Feb 08, 2022

BUY
$4.05 - $5.37 $10,287 - $13,639
2,540 Added 13.56%
21,266 $93,000
Q3 2021

Nov 02, 2021

BUY
$3.89 - $5.48 $6,550 - $9,228
1,684 Added 9.88%
18,726 $81,000
Q2 2021

Aug 11, 2021

BUY
$3.61 - $5.45 $61,521 - $92,878
17,042 New
17,042 $93,000
Q2 2020

Jul 17, 2020

SELL
$0.94 - $2.21 $17,499 - $41,141
-18,616 Closed
0 $0
Q1 2020

Apr 21, 2020

SELL
$0.84 - $1.76 $2,032 - $4,259
-2,420 Reduced 11.5%
18,616 $19,000
Q4 2019

Feb 12, 2020

SELL
$1.14 - $1.49 $3,009 - $3,933
-2,640 Reduced 11.15%
21,036 $27,000
Q3 2019

Nov 07, 2019

BUY
$1.04 - $1.44 $936 - $1,296
900 Added 3.95%
23,676 $30,000
Q2 2019

Aug 06, 2019

BUY
$1.09 - $1.88 $118 - $204
109 Added 0.48%
22,776 $26,000
Q1 2019

May 06, 2019

SELL
$1.14 - $2.25 $17,100 - $33,750
-15,000 Reduced 39.82%
22,667 $45,000
Q4 2018

Feb 11, 2019

BUY
$1.02 - $2.05 $102 - $204
100 Added 0.27%
37,667 $40,000
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $2,089 - $4,531
-2,069 Reduced 5.22%
37,567 $69,000
Q2 2018

Jul 30, 2018

BUY
$1.59 - $2.38 $2,544 - $3,808
1,600 Added 4.21%
39,636 $75,000
Q1 2018

Apr 16, 2018

BUY
$2.28 - $3.8 $51,147 - $85,245
22,433 Added 143.77%
38,036 $87,000
Q4 2017

Feb 09, 2018

SELL
$2.28 - $6.71 $1,153 - $3,395
-506 Reduced 3.14%
15,603 $36,000
Q3 2017

Oct 26, 2017

BUY
$1.15 - $2.29 $6,752 - $13,446
5,872 Added 57.36%
16,109 $35,000
Q2 2017

Aug 15, 2017

BUY
N/A
10,237
10,237 $14,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.